List of Intra-Cellular Therapies patents

List of Intra-Cellular Therapies patents

List of Stitch Fix patents

List of Lightwaves Systems patents

List of Zumtobel Lighting patents

Founders educated at San Francisco State University

Regeneration (biology) venture capital investors

Patents where

Current Assignee

Name

is

Intra-Cellular Therapies

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 12023331 Methods	Patent 12023331 was granted and assigned to Intra-Cellular Therapies on July, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	12023331	July 2, 2024
	‌ US Patent 11124514 Compositions and methods	Patent 11124514 was granted and assigned to Intra-Cellular Therapies on September, 2021 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11124514	September 21, 2021
	‌ US Patent 11096944 Organic compounds	Patent 11096944 was granted and assigned to Intra-Cellular Therapies on August, 2021 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11096944	August 24, 2021
	‌ US Patent 9469647 Salt crystals	Patent 9469647 was granted and assigned to Intra-Cellular Therapies on October, 2016 by the United States Patent and Trademark Office.		Intra-Cellular Therapies		United States Patent and Trademark Office	9469647	October 18, 2016
	‌ US Patent 8779139 Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof	Patent 8779139 was granted and assigned to Intra-Cellular Therapies on July, 2014 by the United States Patent and Trademark Office.		Intra-Cellular Therapies		United States Patent and Trademark Office	8779139	July 15, 2014
	‌ US Patent RE48825 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms	Patent RE48825 was granted and assigned to Intra-Cellular Therapies on November, 2021 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	RE48825	November 23, 2021
	‌ US Patent 11166956 Combinations of PDE1 inhibitors and NEP inhibitors	Patent 11166956 was granted and assigned to Intra-Cellular Therapies on November, 2021 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11166956	November 9, 2021
	‌ US Patent 8470548 Diagnosis of depression	Patent 8470548 was granted and assigned to Intra-Cellular Therapies on June, 2013 by the United States Patent and Trademark Office.		Intra-Cellular Therapies		United States Patent and Trademark Office	8470548	June 25, 2013
	‌ US Patent 12090155 Methods	Patent 12090155 was granted and assigned to Intra-Cellular Therapies on September, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	12090155	September 17, 2024
	‌ US Patent 11980617 Methods of treating acute depression and/or acute anxiety	Patent 11980617 was granted and assigned to Intra-Cellular Therapies on May, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11980617	May 14, 2024
	‌ US Patent 11957791 Methods	Patent 11957791 was granted and assigned to Intra-Cellular Therapies on April, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11957791	April 16, 2024
	‌ US Patent 12128043 Pharmaceutical capsules comprising lumateperone mono-tosylate	Patent 12128043 was granted and assigned to Intra-Cellular Therapies on October, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	12128043	October 29, 2024
	‌ US Patent 11839614 Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A	Patent 11839614 was granted and assigned to Intra-Cellular Therapies on December, 2023 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11839614	December 12, 2023
	‌ US Patent 11872223 Amorphous solid dispersions	Patent 11872223 was granted and assigned to Intra-Cellular Therapies on January, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11872223	January 16, 2024
	‌ US Patent 11958852 Compounds and methods	Patent 11958852 was granted and assigned to Intra-Cellular Therapies on April, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	11958852	April 16, 2024
	‌ US Patent 12070459 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate	Patent 12070459 was granted and assigned to Intra-Cellular Therapies on August, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	12070459	August 27, 2024
	‌ US Patent 12122792 Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders	Patent 12122792 was granted and assigned to Intra-Cellular Therapies on October, 2024 by the United States Patent and Trademark Office.	Intra-Cellular Therapies	Intra-Cellular Therapies		United States Patent and Trademark Office	12122792	October 22, 2024

17 results

0 selected

17 results

0 selected